Clinical Trial

Perioperative Use of Continuous Glucose Monitoring for Scheduled Cesarean Deliveries (PERUSE)

Study acronym: PERUSE
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective pilot study is exploratory in nature and is designed to evaluate the validity of continuous glucose monitor (CGM) use for perioperative glucose surveillance during scheduled Cesarean delivery for nondiabetic patients. Primary objective is characterization of perioperative glucose trends during elective Cesarean delivery in patients without diabetes and exploratory analyses will describe perioperative glucose patterns captured by CGM. Secondary objective is to examine rates of and associations with post-operative complications, including surgical site infections.
Trial Details
NCT Number NCT07671599
Lead Sponsor Icahn School of Medicine at Mount Sinai
Conditions Dysglycemia
Enrollment 150 participants
Start Date 2026-09
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-26